回复 Deora 等人在《人类基因组学》第 18 期上的通信，文章编号：52（2024）：关于 "印度人群中 EGLN1 基因中 rs479200 的 C 等位基因与 COVID-19 严重程度的关联：一项新发现 "的重要见解

IF 3.8 3区医学 Q2 GENETICS & HEREDITY

Human Genomics Pub Date : 2024-09-12 DOI:10.1186/s40246-024-00671-z

Piyoosh Kumar Singh, Renuka Harit, Sajal De, Kailash C Pandey, Kapil Vashisht

{"title":"回复 Deora 等人在《人类基因组学》第 18 期上的通信，文章编号：52（2024）：关于 \"印度人群中 EGLN1 基因中 rs479200 的 C 等位基因与 COVID-19 严重程度的关联：一项新发现 \"的重要见解","authors":"Piyoosh Kumar Singh, Renuka Harit, Sajal De, Kailash C Pandey, Kapil Vashisht","doi":"10.1186/s40246-024-00671-z","DOIUrl":null,"url":null,"abstract":"A reply to the correspondence by Deora et al.- Critical insights on “Association of the C allele of rs479200 in the EGLN1 gene with COVID‑19 severity in Indian population: a novel finding”. The reply contains point-wise rebuttal to the concerns, particularly addressing the epidemiological, statistical, and mathematical issues raised by Deora et al.","PeriodicalId":13183,"journal":{"name":"Human Genomics","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reply to correspondence by Deora et al. in Human Genomics 18, article no.: 52 (2024): critical insights on “Association of the C allele of rs479200 in the EGLN1 gene with COVID‑19 severity in Indian population: a novel finding”\",\"authors\":\"Piyoosh Kumar Singh, Renuka Harit, Sajal De, Kailash C Pandey, Kapil Vashisht\",\"doi\":\"10.1186/s40246-024-00671-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A reply to the correspondence by Deora et al.- Critical insights on “Association of the C allele of rs479200 in the EGLN1 gene with COVID‑19 severity in Indian population: a novel finding”. The reply contains point-wise rebuttal to the concerns, particularly addressing the epidemiological, statistical, and mathematical issues raised by Deora et al.\",\"PeriodicalId\":13183,\"journal\":{\"name\":\"Human Genomics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2024-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human Genomics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40246-024-00671-z\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Genomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40246-024-00671-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}

引用次数: 0

摘要

对 Deora 等人通信的回复--关于 "印度人群中 EGLN1 基因 rs479200 的 C 等位基因与 COVID-19 严重程度的关联：一项新发现 "的重要见解。该答复包含对有关问题的逐点反驳，特别是针对 Deora 等人提出的流行病学、统计学和数学问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Reply to correspondence by Deora et al. in Human Genomics 18, article no.: 52 (2024): critical insights on “Association of the C allele of rs479200 in the EGLN1 gene with COVID‑19 severity in Indian population: a novel finding”

A reply to the correspondence by Deora et al.- Critical insights on “Association of the C allele of rs479200 in the EGLN1 gene with COVID‑19 severity in Indian population: a novel finding”. The reply contains point-wise rebuttal to the concerns, particularly addressing the epidemiological, statistical, and mathematical issues raised by Deora et al.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Human Genomics GENETICS & HEREDITY-

CiteScore

6.00

自引率

2.20%

发文量

审稿时长

11 weeks

期刊介绍： Human Genomics is a peer-reviewed, open access, online journal that focuses on the application of genomic analysis in all aspects of human health and disease, as well as genomic analysis of drug efficacy and safety, and comparative genomics. Topics covered by the journal include, but are not limited to: pharmacogenomics, genome-wide association studies, genome-wide sequencing, exome sequencing, next-generation deep-sequencing, functional genomics, epigenomics, translational genomics, expression profiling, proteomics, bioinformatics, animal models, statistical genetics, genetic epidemiology, human population genetics and comparative genomics.